⭐ Worth Watching

High-impact BSE & NSE announcements curated by AI scores — past 30 days, one per company

⭐ FeaturedNSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026

CORONA Remedies Limited

Analysts/Institutional Investor Meet/Con. Call Updates

CORONA Remedies Limited reported a 21.9% year-on-year revenue growth in Q1 FY27, surpassing its stated growth guidance of 15%. The company's India business delivered an impressive 22.7% year-on-year revenue growth, significantly outperforming the Indian Pharmaceutical Market, which grew by 11.6% during the same period.

⭐ FeaturedBSECompany Update▲ PositiveResults10 Aug 2026

IOL Chemicals & Pharmaceuticals Ltd

Press Release- Financial Results for the quarter ended 30th June 2026

IOL Chemicals & Pharmaceuticals Ltd reported its Q1 FY27 results, with revenue from operations increasing 37.1% YoY to ₹756.3 Cr, EBITDA rising 60.7% YoY to ₹111.7 Cr, and PAT increasing 89.9% YoY to ₹64.5 Cr. The company's Pharmaceuticals business saw a 43% YoY revenue growth and 72% YoY EBIT growth, driven by improved capacity utilisation, favourable product mix, and operational efficiencies.

⭐ FeaturedBSEResult▲ PositiveResults10 Aug 2026

Promact Plastics Ltd

The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th June, 2026. We are enclosing herewith copy of the ....

Promact Plastics Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit of Rs. 1645.04 crore from continuing operations, compared to a loss of Rs. 14.53 crore in the same quarter last year.

⭐ FeaturedBSECompany Update▲ PositiveResults10 Aug 2026

SPR Auto Technologies Ltd

Transcripts

SPR Auto Technologies Ltd has announced its Q1 FY27 earnings, with a 51% year-on-year growth in consolidated total income and a 27% year-on-year growth in consolidated EBITDA. The company has delivered a strong financial performance despite challenging industry conditions, with a 7% year-on-year growth in consolidated profit before tax and a 9% year-on-year growth in profit after tax.

⭐ FeaturedNSEPress Release▲ PositiveOrder Win10 Aug 2026

Jupiter Wagons Limited

Press Release

Jupiter Wagons Limited has secured two significant orders worth over Rs. 211 Crore from JSW Port Logistics Private Limited and Orissa Alloy Steel Private Limited, reinforcing its position as a trusted partner in India's evolving freight logistics sector.

⭐ FeaturedBSECompany Update▲ PositiveResults10 Aug 2026

Shilpa Medicare Ltd

Q1FY27 earnings conference call transcript

Shilpa Medicare Ltd has announced its Q1FY27 earnings conference call transcript, highlighting its strong performance and future growth prospects. The company has reduced its net debt-to-EBITDA ratio to 1.3x and achieved a double-digit ROCE. It has also made significant investments in biologics, CDMO, and novel drug delivery, with plans to monetize these assets in the future.

⭐ FeaturedBSEAGM/EGM▲ PositiveMgmt Change10 Aug 2026

BPL Ltd

Scrutiniser Report for Postal Ballot

BPL Ltd has announced the scrutinizer report for its postal ballot, with 99.96% of shareholders voting in favor of re-appointing Mr. CK Sabareeshan as an independent director for a further period of 5 years. The resolutions stand passed with the requisite majority.

⭐ FeaturedNSEInvestor Presentation▲ PositiveResults10 Aug 2026

Gretex Corporate Services Limited

Investor Presentation

Gretex Corporate Services Limited has submitted a revised investor presentation for the Q1-FY27 earnings call, highlighting strong revenue and profitability growth, with consolidated revenue increasing by 70.5% YoY and PAT margins expanding by 2959 bps YoY.

⭐ FeaturedNSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026

Mayur Uniquoters Ltd

Analysts/Institutional Investor Meet/Con. Call Updates

Mayur Uniquoters Ltd has informed the Exchange about the transcript of Earnings Conference Call held on August 06, 2026. The company has achieved revenue from operations on a standalone basis of INR247.03 crores, PBT of INR77.79 crores, and PAT of INR58.95 crores. The revenue from operations on a consolidated basis is INR269.23 crores, PBT of INR74.12 crores, and PAT of INR56.12 crores. The company has received OEM supply orders from the U.S.A. and has plans to expand its business in the next 2-3 years.

⭐ FeaturedBSECorp. Action▲ PositiveDividend10 Aug 2026

Upsurge Investment & Finance Ltd

The Board in its meeting held on 10.08.2026 has declared interim dividend @ 5% i.e. Re. 0.50 per shares for the financial year 2026-2027

Upsurge Investment & Finance Ltd declared an interim dividend of 5% i.e. Re. 0.50 per equity share for the financial year 2026-2027. The record date for determining the entitlement of shareholders for the payment of the interim dividend is Friday, 21st August, 2026.

⭐ FeaturedNSEGeneral Updates▲ PositiveExpansion10 Aug 2026

K.P.R. Mill Limited

General Updates

K.P.R. Mill Limited has announced a comprehensive capacity expansion and modernization plan across its textile value chain, with a total investment of Rs. 1,225 Crores and expected turnover of Rs. 2,000 Crores.

⭐ FeaturedBSECompany Update▲ PositiveOrder Win10 Aug 2026

Jash Engineering Ltd

Corporate Announcement

Jash Engineering Ltd has commissioned a major expansion in its foundry, increasing casting production by 50%, and expanded its cast gate & cast valve manufacturing capacity by 30%. The company has also received necessary approvals for its proposed Saudi plant and reported a consolidated order book position of Rs. 932 Cr as of 1st August 2026.

⭐ FeaturedNSEInvestor Presentation▲ PositiveResults10 Aug 2026

Power Mech Projects Limited

Investor Presentation

Power Mech Projects Limited has announced its Q1 FY 2027 earnings, with revenue growing 26% YoY to INR 1,624 Cr, EBITDA at INR 176 Cr, and order inflows of INR 1,864 Cr. The company has an order backlog of INR 55,398 Cr and is focused on disciplined execution, improving profitability, and executing the order pipeline across core and emerging businesses.

⭐ FeaturedNSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026

Sanofi India Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Sanofi India Limited has announced its unaudited financial results for the quarter and half year ended 30th June 2026, with a strong momentum in the diabetes business, driven by double-digit growth in the domestic market, powered by innovative portfolio, Toujeo and Soliqua. The company has also reported a 2% growth in quarter two over last year's quarter two, based on the continued ROI from partnership with Emcure and Cipla.

← PreviousPage 31 of 119Next →